Merck & Co., Inc. (NYSE:MRK) is one of the stocks Jim Cramer discussed, along with the tech battleground. Cramer highlighted ...

This degree of success can become a double-edged sword, though. While the drug has thrived since its first approval back in ...

With yields between 3.4% and 6.8%, you'll need to think carefully about the highest yields in the Dow before you buy them.

Kennedy’s advisers scrap hepatitis B vaccine guidance for most children in major policy shift – Nation and World News | West Hawaii Today ...

If you own or are considering buying pharma laggards Pfizer (NYSE: PFE), Bristol Myers Squibb (NYSE: BMY), and Merck (NYSE: ...

Finally, Merck is an excellent dividend stock. It offers a juicy forward yield of 3.2% and has increased its payouts by 93.8% ...

An influential panel of US vaccine advisers voted to revoke a longstanding recommendation that all babies receive hepatitis B shots within 24 hours of birth.

Halozyme is seeing some progress in its global effort to defend intellectual property against alleged infringement by Merck & ...

I've identified three stocks in the S&P 500 index that look like variations on that narrative, and they happen to be the ...

In a setback for Merck, a German court issued a preliminary injunction that prevents the company from distributing a new ...

Halozyme was granted a preliminary injunction that would prevent Merck & Co. from distributing a formulation of Keytruda in Germany as part of a patent-infringement dispute over the cancer treatment.